康哲药业:全年业绩符合预期 新康哲蓄势待发

中金公司
18 Mar

2024 年业绩符合市场预期公司公布2024 年业绩:收入74.69 亿元,同比下滑6.8%;全按药品销售收入86.22 亿元,同比下滑9.0%。归母净利润16.20 亿元,同比下滑32.5%;经调整净利润17.14 亿元,同比下滑36.7%,全年业绩符合市场预期。发展趋势存量品种集采压力24 年基本出清,创新产品收入占比提升。若全按药品销售收入计算,2024 年分产品线来看,心脑血管相关疾病线...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10